CervoMed Inc. (CRVO)

Every figure this model derived for CRVO, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2017-12-31
cash 24,938,172 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 25,992,471 AssetsCurrent 2026-06-30
current liabilities 4,656,117 LiabilitiesCurrent 2025-12-31
equity 22,960,297 StockholdersEquity 2026-06-30
ocf -27,977,672 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 331,295 Revenues 2026-06-30
sbc 1,301,923 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CRVO on one particular measure came for.

RatioValue
current ratio5.58
current ratio reported5.58
dilution pct12.01
revenue growth-95.74
revenue growth per share-96.2
rule of 40-9502.7
sbc pct revenue392.98

What to be careful about

What this model itself distrusts about CRVO's figures. Written by the derivation as it ran, not added afterwards.